1.

Record Nr.

UNISA990002946970203316

Titolo

Rapport annuel du Fonds de cohésion / Commissione européenne

Pubbl/distr/stampa

Luxembourg : Office des publications officielles des Communautés européennes

ISSN

1561-2147

Descrizione fisica

v. ; 30 cm

Disciplina

338.9402

Soggetti

Unione europea -- Politica economica

Lingua di pubblicazione

Francese

Formato

Materiale a stampa

Livello bibliografico

Periodico

Note generali

Comincia nel 1996

Descrizione basata su: 2002

2.

Record Nr.

UNINA9910455937803321

Titolo

Workshop and commissioned papers [[electronic resource] ] : ethical and legal issues of including women in clinical studies / / Anna C. Mastroianni, Ruth Faden, and Daniel Federman, editors ; Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Division of Health Sciences Policy, Institute of Medicine

Pubbl/distr/stampa

Washington, D.C., : National Academy Press, 1994

ISBN

1-280-19573-8

9786610195732

0-309-58650-X

0-585-13756-0

Descrizione fisica

1 online resource (264 p.)

Collana

Women and health research ; ; v.2

Altri autori (Persone)

FadenRuth R

FedermanDaniel D. <1928->

MastroianniAnna C

Disciplina

174/.28

Soggetti

Human experimentation in medicine - Law and legislation

Human experimentation in medicine - Moral and ethical aspects

Women - Health and hygiene - Research - Moral and ethical aspects

Electronic books.



Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

""WOMEN AND HEALTH RESEARCH""; ""Copyright""; ""Preface""; ""Contents""; ""Women's Participation in Clinical Research: From Protectionism to Access""; ""CURRENT FEDERAL POLICY""; ""PROTECTIONIST POLICIES""; ""ADVENT OF INCLUSIONARY POLICIES""; ""CONCLUSION""; ""NOTES""; ""Women in Clinical Studies: A Feminist View""; ""NOTES""; ""Ethical Issues Related to the Inclusion of Pregnant Women in Clinical Trials (I)""; ""THE PREGNANT WOMAN AS SUBJECT""; ""Therapeutic: To Meet the Health Needs of the Mother""; ""Nontherapeutic Research: Not Meeting the Health Needs of the Pregnant Woman""

""THE FETUS AS SUBJECT""""Therapeutic: To Meet the Health Needs of the Fetus""; ""Nontherapeutic Fetal Research: Not to Meet the Fetus's Health Needs""; ""NOTES""; ""Ethical Issues Related to the Inclusion of Pregnant Women in Clinical Trials (II)""; ""REFERENCES""; ""Ethical Issues Related to the Inclusion of Women of Childbearing Age in Clinical Trials""; ""NOTES""; ""Health Consequences of Exclusion or Underrepresentation of Women in Clinical Studies (I)""; ""TYPES OF INFORMATION DEFICITS""; ""TYPES OF CONSEQUENCES""; ""Morbidity and Mortality""; ""Diagnosis and Treatment Patterns""

""Treatment Outcomes""""Provider Perceptions""; ""CONCLUSIONS""; ""NOTES""; ""Health Consequences of Exclusion or Underrepresentation of Women in Clinical Studies (II)""; ""Recruitment and Retention of Women in Clinical Studies: Theoretical Perspectives and Methodological Considerations""; ""THE DYNAMICS OF RECRUITMENT AND RETENTION""; ""CROSS-CULTURAL DIFFERENCES: MEN VS. WOMEN""; ""GENDER DIFFERENCES: IMPLICATIONS FOR RESEARCH""; ""METHODOLOGICAL CONSIDERATIONS FOR RESEARCHERS""; ""REFERENCES""; ""Recruitment and Retention of Women of Color in Clinical Studies""; ""NOTES""

""Recruitment and Retention of Women in Clinical Studies: Ethical Considerations""""INCENTIVES TO ENROLL AND TO CONTINUE PARTICIPATION""; ""FREE ABORTION AS AN INCENTIVE""; ""DEALING WITH DROPOUTS""; ""COSTS OF INVOLVING WOMEN AS RESEARCH SUBJECTS""; ""TWO SEPARATE AGENDAS ON THE INCLUSION OF WOMEN""; ""WOMEN IN (SOME) DEVELOPING COUNTRIES""; ""REFERENCES""; ""Impact of Current Federal Regulations on the Inclusion of Female Subjects in Clinical Studies""; ""THE IMPACT OF PRESENT LAW""; ""Regulations that Appear to Limit Women's Participation in Clinical Research""

""FDA Definition of ""Childbearing Potential"" and Required Prior Reproductive Studies""""DHHS Limitations on Research with Pregnant Women""; ""Federal Requirements that Support the Inclusion of Women in Clinical Research""; ""FDA Premarketing Testing""; ""DHHS Regulations on Research with Children""; ""RECOMMENDED CHANGES IN THE FEDERAL LAW""; ""Amendment of FDA Regulations""; ""Amendment of DHHS Regulations""; ""National Institutes of Health Policy""; ""CONCLUSION""; ""NOTES""; ""Brief Overview of Constitutional Issues Raised by the Exclusion of Women from Research Trials""

""DISPARATE TREATMENT, DISPARATE BENEFITS, AND EQUAL OPPORTUNITY""



3.

Record Nr.

UNINA9910457240603321

Titolo

Protecting the frontline in biodefense research [[electronic resource] ] : the Special Immunizations Program / / National Research Council of the National Academies

Pubbl/distr/stampa

Washington, D.C., : National Academies Press, c2011

ISBN

1-283-21341-9

9786613213419

0-309-20925-0

Descrizione fisica

1 online resource (183 p.)

Disciplina

358.38

Soggetti

Biological warfare - Research - Safety measures

Biological warfare - Research - Health aspects

Vaccines - United States

Medicine, Military - United States

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Selected Agents, Board on Life Sciences, Division on Earth and Life Studies."

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""Front Matter""; ""Acknowledgments""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 History of the Special Immunizations Program and Lessons Learned from Occupational Immunization Against Hazardous Pathogens""; ""3 The U.S. Medical Countermeasures Enterprise and Recent Reviews and Current Operation of the Special Immunizations Program""; ""4 Regulations and Other Guidance Pertaining to the Development and Use of Vaccines in the Special Immunizations Program""; ""5 New Vaccine Development and the Future Needs of the Special Immunizations Program""

""6 Potential Options for the Special Immunizations Program and for Personnel Immunization""""7 Conclusions and Recommendations""; ""References""; ""Appendixes""; ""Appendix A: Committee Member Biographies""; ""Appendix B: Abbreviations and Acronyms""; ""Appendix C: Glossary""



Sommario/riassunto

"The U.S. Army's Special Immunizations Program is an important component of an overall biosafety program for laboratory workers at risk of exposure to hazardous pathogens. The program provides immunizations to scientists, laboratory technicians and other support staff who work with certain hazardous pathogens and toxins. Although first established to serve military personnel, the program was expanded through a cost-sharing agreement in 2004 to include other government and civilian workers, reflecting the expansion in biodefense research in recent years. Protecting the Frontline in Biodefense Research examines issues related to the expansion of the Special Immunizations Program, considering the regulatory frameworks under which the vaccines are administered, how additional vaccines might be considered for inclusion in the Program, and factors that might influence the development and manufacturing of vaccines for the Special Immunizations Program."--Publisher's description.